FDA lifts hold on CRISPR, Vertex sickle cell trial

CRISPR Therapeutics and Vertex Pharmaceuticals announced that the U.S. FDA has lifted the clinical hold and accepted the Investigational New Drug application for a new treatment for sickle cell disease.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news